AstraZeneca PLC (OTCMKTS:AZNCF) Short Interest Update

AstraZeneca PLC (OTCMKTS:AZNCF) was the recipient of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 67,800 shares, a growth of 15.9% from the March 15th total of 58,500 shares. Based on an average daily volume of 3,300 shares, the short-interest ratio is currently 20.5 days.

AstraZeneca Trading Down 2.1 %

AstraZeneca stock opened at $135.94 on Tuesday. AstraZeneca has a fifty-two week low of $118.16 and a fifty-two week high of $153.10. The firm has a 50 day moving average price of $131.07 and a 200 day moving average price of $130.68.

AstraZeneca Increases Dividend

The business also recently announced a dividend, which was paid on Monday, March 25th. Investors of record on Friday, February 23rd were issued a $1.97 dividend. The ex-dividend date was Wednesday, February 21st. This is an increase from AstraZeneca’s previous dividend of $0.93. AstraZeneca’s dividend payout ratio (DPR) is 343.14%.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.